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Abstract
Background: Patients with obesity, diabetes, and chronic kidney disease (CKD) are generally
physically inactive, have a high mortality rate, and may benefit from an exercise program.
Methods: We performed a 24-week randomized controlled feasibility study comparing aerobic
exercise plus optimal medical management to medical management alone in patients with type 2
diabetes, obesity (body mass index [BMI] > 30 kg/m2), and stage 2-4 CKD (estimated glomerular
filtration rate [eGFR] 15-90 mL/min/1.73 m2 with persistent proteinuria). Subjects randomized to
exercise underwent thrice weekly aerobic training for 6 followed by 18 weeks of supervised home
exercise. The primary outcome variable was change in proteinuria.
Results: Seven subjects randomized to exercise and 4 control subjects completed the study.
Exercise training resulted in an increase in exercise duration during treadmill testing, which was
accompanied by slight but insignificant decreases in resting systolic blood pressure and 24-hour
proteinuria. Exercise did not alter GFR, hemoglobin, glycated hemoglobin, serum lipids, or C-
reactive protein (CRP). Caloric intake and body weight and composition also did not change with
exercise training.
Conclusion: Exercise training in obese diabetic patients with CKD is feasible and may have clinical
benefits. A large-scale randomized controlled trial to determine the effects of exercise on renal
functions, cardiovascular fitness, inflammation, and oxidative stress in diabetic patients with CKD
is planned.
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Background
Diabetes mellitus now affects approximately 250 million
people worldwide, a figure expected to reach 400 million
(approximately 7% of the adult population) by 2025 [1].
This global epidemic of diabetes is in large part due to
obesity and sedentary lifestyle. Increasing numbers of
patients with diabetic complications will impose an enor-
mous burden on the healthcare system [2,3]. Kidney dis-
ease is the most feared complication of diabetes, due to its
substantial co-morbidity (need for dialysis, blindness,
amputations, etc.), cost, and mortality (the annual mor-
tality rate of diabetic patients with kidney failure on dial-
ysis is about 25%) [4]. The major determinants of kidney
disease and its progression to end-stage kidney failure in
type 2 diabetes are uncontrolled blood glucose, blood
pressure and albuminuria [5-7]. The Steno-2 study pro-
vides good evidence that further improvements in out-
come can only be achieved through multifactorial
intervention, consisting of lifestyle modifications in addi-
tion to pharmacologic measures [8].
Regular exercise with [9,10] or without [9,11,12] dietary
intervention and/or oral blood glucose-lowering medica-
tion [13,14] has been shown to have benefits in patients
with Type 2 diabetes. However, most of these studies were
done in subjects with newly-diagnosed diabetes without
complications and/or only insulin resistance. Current
guidelines from the American Diabetes Association
(ADA) and the European Association for the Study of Dia-
betes recognize the value of exercise [15-17]. However,
there is no evidence that exercise will prevent or amelio-
rate complications such as chronic kidney disease (CKD)
in this population.
The present study seeks to investigate the hypothesis that
increasing energy expenditure by aerobic exercise will
have cardiovascular benefits, including decreased blood
pressure, decreased heart rate, and increased exercise tol-
erance, and will result in a decrease in proteinuria in obese
diabetic patients with CKD. We also wished to determine
if exercise would result in weight loss and improved body
composition, improved glucose and lipid control, and a
decrease in inflammation.
Methods
Study Design
This was a 24-week randomized controlled pilot study.
After baseline screening, subjects were randomized to an
exercise or control group. Subjects randomized to exercise
underwent thrice weekly training for 6 weeks in the
research exercise laboratory at Hines VA Hospital, fol-
lowed by 18 weeks of supervised home exercise. Both
groups received standard of care medical treatment for
diabetes and CKD, including diabetes education. The pri-
mary outcome variable was change in proteinuria. Exer-
cise training parameters (resting and maximal blood
pressure, heart rate, and oxygen consumption), hemo-
globin, glycated hemoglobin, lipid profile, C-reactive pro-
tein (CRP), dietary caloric intake, and body weight and
composition were secondary outcome variables. This
research was carried out in compliance with the Helsinki
Declaration and was approved by the Hines VA IRB. Writ-
ten informed consent was obtained from each participant.
Study Sample
Our study sample consisted of 20 subjects from the renal
outpatient clinic of Hines VA Hospital with type 2 diabe-
Table 1: Study Inclusion and Exclusion Criteria
Inclusion Criteria Exclusion Criteria
CKD Stages 2-4 CKD stages other than 2-4
BMI ≥ 30 Hyperparathyroidism/osteoporosis
Diabetes mellitus Symptomatic neuropathy/retinopathy
Proteinuria (urine protein/creatinine > 200 mg/g for ≥ 3 months) Positive stress test due to coronary arterial disease
Treatment with ACE inhibitor or ARB, aspirin, and statin (if LDL > 100) Symptomatic cardiovascular disease
Congestive heart failure (New York Heart Association Class III or IV)
Chronic obstructive pulmonary disease 
(FEV1 < 50% predicted and/or requires supplemental oxygen support 
during exercise)
Complaints of angina during the stress test
Cerebrovascular disease/cognitive impairment
Renal transplant
Inability to walk on the treadmill
Any unforeseen illness or disability that would preclude exercise testing 
or training
Participation in a formal exercise program within the previous 12 weeks
BMI = body mass index (kg/m2), FEV1 = forced expiratory volume in one second; ACE = angiotensin converting enzyme; ARB = angiotensin 
receptor blocker; LDL = low density lipoproteinCardiovascular Diabetology 2009, 8:62 http://www.cardiab.com/content/8/1/62
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tes, obesity (BMI > 30 kg/m2), and stage 2-4 CKD (eGFR
15-90 mL/min/1.73 m2 with persistent proteinuria, i.e.
urine protein/creatinine > 200 mg/g for ≥ 3 months) (see
Table 1 for inclusion and exclusion criteria).
Study Procedures
All subjects underwent a full history and physical exami-
nation and an electrocardiogram (ECG). They then under-
went a symptom-limited, treadmill, exercise stress test. If
the stress test was negative, the patient was continued in
the study and asked to complete questionnaires, nutri-
tional assessment, and laboratory tests. After all baseline
data were obtained, if patients were still eligible, they were
randomized using a 2 × 2 block randomization scheme to
the exercise or control group. The above testing was
repeated after 6 weeks (at the end of the training period)
and 24 weeks (end of study).
Aerobic Training Protocol
Individuals assigned to the exercise group received
instruction in walking and proper walking shoe selection.
An introductory session was completed to educate the
patient on developing a walking program, familiarize
him/her with the lab and practice walking on treadmill.
Each exercise training session included 3 to 5 minutes of
warm-up, range-of-motion exercises, interval training,
cool-down, and post-exercise range-of-motion exercises.
Each subject's training program was individualized and
based on the results of the baseline exercise tests. Exercise
intensities listed in Table 2 served as a guide for exercise
prescription. Total exercise time began at 30 minutes and
gradually increased by 5 minutes every two weeks.
Patients were not allowed to exercise at a heart rate
beyond that achieved on the maximal exercise test. Train-
ing was completed on the treadmill, outside (weather per-
mitting) or in the research building corridors. After six
weeks of supervised training, subjects were expected to
continue their walking program unsupervised in their
community and to increase their step count/structured
walk by 10% each week. Study staff called them weekly to
ask about step counts and their walking program.
Exercise-induced Hypoglycemia
To prevent exercise-induced hypoglycemia, patients were
exercised one to two hours after a meal (generally after
breakfast). A fingerstick blood glucose was performed
prior to exercising; if the glucose was <110 mg/dL, 30 g of
carbohydrate was administered prior to exercising.
Control group protocol
Control patients underwent the same testing battery but
did not participate in any exercise training.
Specific Methods
Symptom-limited treadmill test protocol
Subjects exercised on a treadmill (Marquette Series 2000
treadmill) attached to an ECG monitor. Exercise began at
0% grade and a speed of 1.8 mph. Increases in percent
grade occurred every 30 seconds, and, after the first six
minutes, speed increased every three minutes. The follow-
ing measurements were made during all exercise tests.
Oxygen uptake was determined using the MedGraphics
CPX/MAX/D™ system for breath by breath analysis (St.
Paul, MN). Prior to each test, the analyzers were calibrated
with reference gases and room air. Heart rate was derived
from a standard ECG. A Marquette CASE (Cardiac Assess-
ment System for Exercise Testing) system was used for
continuous visual monitoring and recording ECG. A 12-
lead ECG was taken every minute during all exercise tests.
Blood pressure (BP) was determined by the auscultatory
technique, using a sphygmomanometer, a pre-gauged
adult cuff, and a stethoscope. The first and last Korotkoff
sounds were recorded. BP was taken pre-exercise, every
two minutes while the subject was exercising, and every
minute post-exercise until the patient's BP approached
baseline values.
Nutritional and Body Composition Assessment
Subjects reported a food record at baseline and then were
asked to keep 6 non-consecutive days of food records dur-
ing the first 6 weeks and then every 3 weeks during weeks
7-24. Average daily intake in kilocalories (kcal) was calcu-
lated using Food Processor SQL Edition (Version 9.5.0,
ESHA Research, Salem, Oregon, Copyright 2004). In addi-
tion, the Harris-Benedict equation (HBE) with appropri-
ate adjustment for activity level was used to estimate
energy requirements (kcal) for each subject.
BEE Basal Energy Expenditure
BEE body wt  kg
=
=+ × +  66 13 7 5 [. () ][ × ×− ××
=+×
ht cm age yr activity  factor
BEE bod
() ] [ . ( ) ]
[.
68
655 9 6  y y wt  kg ht  cm age  yr activity factor () ][ . ( ) ][ . () ] +× −× × 18 47
Table 2: Exercise Training Schedule
Weeks Light
(25-44% VO2 peak)
Moderate
(45-59% VO2 peak)
Hard
(60-84% VO2 peak)
Very Hard
(>85% VO2 peak)
1-3 20% (6 min) 60% (18 min) 20% (6 min) 0%
4-6 15% (6 min) 55% (22 min) 30% (12 min) 0%
Percent time spent at a given exercise training intensity (% peak VO2) for exercise group (approximate minutes at each intensity are in parenthesis). 
Values expressed in the table are a percentage of the total workout time (e.g., 10 min of a 30 minute workout = 33%). Total exercise time begins at 
30 minutes and increases by 5 minutes every two weeks until 40 minutes is achieved while supervised.Cardiovascular Diabetology 2009, 8:62 http://www.cardiab.com/content/8/1/62
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Assessment of body fat/composition was measured by air
displacement plethysmography (ADP) (BOD POD, Life
Measurement, Inc., Concord, CA USA) [18]. After body
volume was determined, thoracic gas volume was deter-
mined in order to allow determination of percentage lean
and fat weight. The BOD POD is analogous to underwater
weighing without having to go under water (air displace-
ment is used instead of water displacement) and has been
used in subjects up to 500 pounds with high accuracy.
Laboratory values measured included serum urea nitro-
gen and creatinine, urea and creatinine clearances (to cal-
culate glomerular filtration rate), random urine albumin/
creatinine and protein/creatinine ratios, 24-hour urine
protein excretion, hemoglobin, glycated hemoglobin,
lipid profile, and C-reactive protein (CRP). These tests
were done at baseline, at the end of exercise training (6
weeks), and at study completion (24 weeks).
Data Analysis
We performed within-group and between-group compar-
isons using mixed-effect linear regression models that
included indicators for group (control vs. intervention),
time (in weeks), and an interaction term (group × time).
To address the possible correlation of an individual's
measures over time, the models included a random effect.
For analytic purposes, urine protein data were log trans-
formed in order to normalize the data. A P-value of < 0.05
was taken to be significant.
Results
Twenty patients were recruited and signed the consent
form. One subject did not qualify based on screening lab-
oratory tests. Of the remaining 19 subjects, 6 were
dropped from the study due to a positive stress test (2
patients), investigator decision (2 patients), patient wish
(1 patient), and commencement of hemodialysis (1
Plot depicting effect of exercise on proteinuria in 7 subjects undergoing exercise training (structured exercise training for 6  weeks followed by home exercise for 18 weeks) Figure 1
Plot depicting effect of exercise on proteinuria in 7 subjects undergoing exercise training (structured exercise 
training for 6 weeks followed by home exercise for 18 weeks)
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patient). Thirteen subjects were then randomized, 7 to the
exercise group and 6 to the control group. Two of the 6
control subjects were dropped subsequent to randomiza-
tion and prior to any testing (due to investigator decision
and patient wish, respectively), leaving 4 subjects in the
control group. All subjects were male; mean age was 66
(range 55-81).
Data for the exercise and control group patients are given
in Tables 3 and 4. Thrice weekly exercise training for 6
weeks followed by 18 weeks of home exercise resulted in
an increase in exercise duration during treadmill testing at
6 weeks, which persisted until 24 weeks. There was a ten-
dency for oxygen consumption at isotime during the
treadmill testing to decrease (isotime is defined as a time
when workload was the same in all subjects), which was
accompanied by a slight decrease in resting systolic blood
pressure, again suggesting a training effect. There was also
a trend toward a decrease in 24-hour proteinuria (Figure
1). However, there were no significant between-groups
effects over time for exercise duration, oxygen consump-
tion at isotime, blood pressure, or 24-hour proteinuria,
probably due to the small sample size. Six weeks of exer-
cise training did not affect GFR nor improve hemoglobin
or biochemical parameters such as glycated hemoglobin
and serum lipids, and did not diminish CRP (as a marker
of inflammation). Caloric intake and body weight and
composition also did not change with exercise training.
Discussion
To our knowledge, this is the first randomized controlled
trial that has examined the effects of exercise training in
Table 3: Data in Subjects Randomized to Exercise
Exercise Parameters Baseline 6 weeks 24 weeks
Exercise duration (min) 6.6 ± 2.2 11.3 ± 2.4 10.2 ± 2.8
Maximal oxygen consumption (mL/kg/min) 14.9 ± 1.1 13.8 ± 3.9 15.6 ± 2.4
Oxygen consumption (isotime) (mL/kg/min) 11.9 ± 1.7 10.0 ± 0.7 9.8 ± 1.4
Resting heart rate (bpm) 80 ± 16 82 ± 22 81 ± 21
Maximum heart rate (bpm) 116 ± 16 121 ± 14 118 ± 17
Resting systolic blood pressure (mmHg) 130 ± 28 132 ± 13 113 ± 16
Resting diastolic blood pressure (mmHg) 71 ± 20 71 ± 11 65 ± 10
Maximum systolic blood pressure (mmHg) 182 ± 16 188 ± 24 165 ± 21
Maximum RPP# 21094 ± 3475 22616 ± 1983 19206 ± 1402
Mean ± SD
# rate pressure product = heart rate × systolic blood pressure
Renal Function Parameters Baseline 6 weeks 24 weeks
Serum creatinine (mg/dL) 2.9 ± 1.5 2.7 ± 1.3 2.8 ± 1.2
Serum urea nitrogen (mg/dL) 64 ± 40 58 ± 48 57 ± 34
Creatinine clearance (mL/min) 64 ± 54 62 ± 40 51 ± 26
Urea clearance (mL/min) 24 ± 20 28 ± 22 26 ± 19
Glomerular filtration rate (mL/min)# 44 ± 36 45 ± 31 39 ± 22
Urine albumin/creatinine (mg/g) 327 ± 385 242 ± 260 305 ± 456
Urine protein/creatinine (mg/g) 565 ± 600 419 ± 417 493 ± 544
Urine protein excretion (mg/24 h) 1020 ± 1081 891 ± 831 821 ± 1010
# (Creatinine clearance + urea clearance)/2
Biochemical Parameters Baseline 6 weeks 24 weeks
Hemoglobin (g/dL) 12.7 ± 2.1 12.7 ± 2.2 12.5 ± 1.8
Total cholesterol (mg/dL) 125 ± 25 116 ± 17 128 ± 25
Low density cholesterol (mg/dL) 59 ± 17 51 ± 16 54 ± 11
High density cholesterol (mL/min) 38 ± 6 37 ± 5 39 ± 7
Triglycerides (mg/dL) 137 ± 45 144 ± 60 179 ± 89
Glycated hemoglobin (%) 7.4 ± 1.1 7.5 ± 1.2 8.3 ± 2.4
C-reactive protein (mg/dL) 0.55 ± 0.72 0.72 ± 0.99 0.89 ± 0.92
Nutrition/Body Composition Parameters Baseline 6 weeks 24 weeks
Calorie intake (kcal/day) 1878 ± 563 2011 ± 396 1939 ± 656
Body weight (kg) 116 ± 27 116 ± 26 115 ± 23
Fat weight (%) 40 ± 3 40 ± 3 40 ± 4
Lean weight (%) 60 ± 3 60 ± 3 60 ± 4Cardiovascular Diabetology 2009, 8:62 http://www.cardiab.com/content/8/1/62
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diabetic patients with CKD. However, there have been a
few previous studies that have examined the effects of
exercise on renal function in primarily non-diabetic CKD
patients. Boyce et al. found, in a crossover-design trial,
that four months of exercise training, via stationary
cycling, in sixteen non-dialysis CKD subjects (of whom 8
completed the trial) decreased blood pressure (systolic
and diastolic), increased peak oxygen consumption, but
had no effect on declining GFR [19]. In another non-ran-
domized trial, Clyne et al. found that exercise training for
3 months via bicycle ergometry in 10 predialytic CKD
patients increased maximal exercise capacity and
decreased heart rate at equal load and increased thigh
muscular function assessed by static and dynamic endur-
ance, but these benefits were not associated with
improved hemoglobin, GFR, blood pressure, or echocar-
diographic findings [20]. In a randomized study of 30
patients with moderate CKD, Eidemak et al. found that
aerobic exercise increased maximum work capacity but
had no effect on declining GFR over a 20-month observa-
tion period [21]. The lack of effect of land-based exercise
on renal function is consistent with experimental findings
in rats with renal mass reduction, in which treadmill exer-
cise for 60 days did not improve GFR [22]. In distinction
to these primarily negative studies, Pechter et al. reported
that a 12-week low-intensity aquatic exercise program in
26 patients with mild to moderate CKD resulted in
decreased blood pressure, decreased proteinuria, and a
slight improvement in GFR. This was associated with a
decrease in systolic and diastolic blood pressure and oxi-
Table 4: Data in Control Subjects
Exercise Parameters Baseline 6 weeks 24 weeks
Exercise duration (min) 4.3 ± 1.1 5.5 ± 3.2 6.6 ± 2.1
Maximal oxygen consumption (mL/kg/min) 10.9 ± 1.0 11.8 ± 2.0 11.9 ± 1.3
Oxygen consumption (isotime) (mL/kg/min) 9.1 ± 0.3 9.0 ± 0.2 9.8 ± 0.5
Resting heart rate (bpm) 75 ± 16 76 ± 10 70 ± 19
Maximum heart rate (bpm) 112 ± 16 107 ± 16 105 ± 13
Resting systolic blood pressure (mmHg) 157 ± 14 156 ± 23 136 ± 5
Resting diastolic blood pressure (mmHg) 83 ± 20 77 ± 12 77 ± 8
Maximum systolic blood pressure (mmHg) 207 ± 28 188 ± 47 184 ± 22
Maximum RPP# 23219 ± 6046 20939 ± 7809 19373 ± 4215
Mean ± SD
# rate pressure product = heart rate × systolic blood pressure
Renal Function Parameters Baseline 6 weeks 24 weeks
Serum creatinine (mg/dL) 2.3 ± 0.1 2.1 ± 0.2 2.1 ± 0.4
Serum urea nitrogen (mg/dL) 45 ± 11 48 ± 12 50 ± 18
Creatinine clearance (mL/min) 66 ± 19 54 ± 22 64 ± 10
Urea clearance (mL/min) 28 ± 0.2 18 ± 5.7 19 ± 0.5
Glomerular filtration rate (mL/min)# 47 ± 9.5 36 ± 14 41 ± 5.3
Urine albumin/creatinine (mg/g) 156 ± 148 162 ± 173 221 ± 304
Urine protein/creatinine (mg/g) 347 ± 178 305 ± 186 387 ± 374
Urine protein excretion (mg/24 h) 542 ± 258 383 ± 256 490 ± 237
# (Creatinine clearance + urea clearance)/2
Biochemical Parameters Baseline 6 weeks 24 weeks
Hemoglobin (g/dL) 11.8 ± 1.9 12.0 ± 1.8 11.9 ± 1.3
Total cholesterol (mg/dL) 152 ± 38 160 ± 53 146 ± 31
Low density cholesterol (mg/dL) 75 ± 24 80 ± 41 69 ± 22
High density cholesterol (mL/min) 33 ± 6 31 ± 3 31 ± 4
Triglycerides (mg/dL) 223 ± 92 245 ± 44 225 ± 104
Glycated hemoglobin (%) 8.2 ± 1.7 8.7 ± 2.6 8.1 ± 3.7
C-reactive protein (mg/dL) 1.7 ± 2.4 0.73 ± 0.32 1.17 ± 0.71
Body Composition Parameters Baseline 6 weeks 24 weeks
Calorie intake (kcal/day) 1869 ± 13 2165 ± 658 2192 ± 537
Body weight (kg) 140 ± 15 139 ± 15 136 ± 20
Fat weight (%) 50 ± 5 53 ± 3 50 ± 5
Lean weight (%) 50 ± 5 47 ± 3 50 ± 5Cardiovascular Diabetology 2009, 8:62 http://www.cardiab.com/content/8/1/62
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dative stress indices (lipid peroxidation products and
reduced glutathione) [23]. Aquatic exercise may thus
decrease proteinuria and improve GFR, as was shown pre-
viously in rats with subtotal nephrectomy [24]. However,
the results of this study must be interpreted with caution
due to its non-randomized design. Moreover, whether or
not the putative salutary effects of aquatic exercise can be
extended to land-based aerobic exercise is unclear, as
water immersion is known to improve renal function,
probably due to an improvement in renal hemodyanam-
ics associated with decreases in vasopressor and increases
in vasodepressor hormones [25].
Diabetic patients with CKD and overt albuminuria typi-
cally develop progressive kidney failure [7]. Therefore, the
effects of exercise on albuminuria and progression of kid-
ney disease in this population is of great clinical impor-
tance. Albuminuria in type 2 diabetic patients is
associated with endothelial dysfunction and low-grade
inflammation [26]. Exercise is associated with a decrease
in inflammation, and there is a positive association
between inflammation and microalbuminuria [27]. Thus
an exercise-induced reduction in inflammation and/or
oxidative stress might be expected to decrease proteinuria.
Cytokines and inflammatory markers may directly medi-
ate glomerular and renal damage leading to albuminuria
and renal failure [28]. We did not find significant changes
in proteinuria or C-reactive protein in our study, but this
can probably be explained by the substantial intra-patient
variability and small sample size.
We also did not find any changes in glycated hemoglobin,
lipid profile, or body weight or composition. Although all
subjects did receive nutritional counseling, they did not
specifically undergo caloric restriction or other forms of
dietary modification. It is likely that a more prolonged
and intensive exercise training program or an exercise pro-
gram coupled with calorie restriction would have been
required to result in weight loss and a decrease in fat mass.
In this regard, long-term (1 year) aerobic coupled with
resistance training has been reported to improve these
parameters in type 2 diabetic patients without kidney dis-
ease and only mild obesity (BMI 30) [13]. Renal function
and proteinuria were not assessed in that study.
Conclusion
In summary, we have demonstrated in a pilot study that
exercise training in obese diabetic patients with CKD is
feasible and may have clinical benefits. A larger-scale ran-
domized controlled trial to determine the effects of exer-
cise on renal functions, cardiovascular fitness,
inflammation, and oxidative stress in diabetic patients
with CKD is planned.
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